| [1] |
LYU Dan, LAN Bo, LIU Binliang, MA Fei.
Clinical research of Xinmailong injection in reducing cardiovascular toxicity associated with adjuvant chemotherapy after breast cancer surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 548-554.
|
| [2] |
MA Zhongjing, ZHANG Yanli, CHEN Pan, CHEN Junyi, LI Jia, ZHANG Jingjiao, LIU Ying, XIA Yunlong, FANG Fengqi.
Clinical features and risk factors of Trastuzumab-induced cardiotoxicity in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 555-561.
|
| [3] |
CHEN Yunyun, LI Yuan, WU Qing, FANG Qiong.
Network analysis of core symptoms and symptom clusters in breast cancer patients undergoing ovarian function suppression therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 590-597.
|
| [4] |
ZHOU Jing, LI Jun, LI Hui, LI Min.
Clinicopathological analysis of duodenal-type follicular lymphoma and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 598-603.
|
| [5] |
ZHANG Xiaoyan, CUI Haiyan, GOU Yuting, LI Yongxiang, WANG Yiyang, GUO Chenming.
Multi-omics characteristics of BEND3 in breast cancer and its role in promoting proliferation and metastasis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 627-339.
|
| [6] |
LIANG Kexin, LIANG Zhuxiao, ZHANG Weiqing.
Ru nanoparticles⁃carbon support synergize photothermal⁃chemodynamic therapy to inhibit the proliferation and migration of breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(4): 408-415.
|
| [7] |
ZHANG Zhixing, LI Chunjun, ZHANG Dongdong, CHEN Xiaoyu, HUANG Yuzhen, ZENG Lixia.
Clinicopathological implications of tertiary lymphoid structures in HER2⁃low breast cancer in women of reproductive age
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(4): 440-445.
|
| [8] |
LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui.
Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
|
| [9] |
YANG Jun, KANG Wei, ZHONG Wuning, ZHAO Xin.
Predictive value of radiomics model based on cone-beam breast CT images for pathological complete response of neoadjuvant therapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 103-108.
|
| [10] |
ZHANG Xiaomeng, WANG Yue, WAN Qiaoqin.
Summary of evidence for the management of drug-related symptoms during endocrine therapy in breast cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 615-621.
|
| [11] |
ZHANG Yening, PANG Ying, HE Yi, TANG Lili.
Status quo and reflections on psychological pain and psychotherapy in patients with advanced breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 622-628.
|
| [12] |
LI Tingting, LIU Yan .
Comparison of the separation and purification methods of small extracellular vesicles in mesenchymal stem cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 424-432.
|
| [13] |
XIE Changquan, HE Fengyi, LU Guodong, LI Qiuyun.
Andrographolide combined with doxorubicin induces cell death in breast cancer cell via ROS-dependent DNA damage
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 302-307.
|
| [14] |
WU Hualing, LIN Qing .
Analysis of clinical and dosimetric factors related to radiation pneumonitis after intensity-modulated radiotherapy in breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 327-331.
|
| [15] |
LUO Xianting, FENG Yimin, ZHOU Jing, XIAO Lei, YIN Jiayu, ZHAO Xin, SU Danke.
Value of Kaiser score-based MRI feature nomogram model in preoperative prediction of vascular invasion in mass breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 332-338.
|